From October 30 to November 1, 2025, Athens hosted the Venous Symposium Europe, a major event for the vascular community. IDNEST Medical was present to confirm the maturity of its solution.
The T-Stent put to the test in an experimental model
We would like to thank the organizing committee as well as Prof. Olivier Hartung for his remarkable presentation. He presented the T-Stent solution dedicated to the treatment of Nutcracker Syndrome, emphasizing its successful deployment in an experimental model.
This technical demonstration is essential: it proves the feasibility and precision of our delivery system before its application in humans.
Heading towards clinical studies (First In Human)
This participation marks a strategic turning point. As announced during the symposium, IDNEST Medical is now fully engaged in the final stages of Verification & Validation (V&V).
The message is clear: the technology is ready to pass the decisive milestone. We are actively preparing for the “First In Human” clinical study, which will bring years of research and development to fruition.
A collective success
This breakthrough is the result of close collaboration with our technological and medical partners. A big thank you to GEPROMED, PROTOMED SA, 3Deus Dynamics, INNOMedX, and Prof. Nabil Chakfe for their expertise and constant support in this journey.